Loading...

PLUR PLURI INC Contract Awards 8-K Filing

PLR

PLR

PLURI INC

(PLUR)

2025 8-K

Securities Purchase Agreement

Nasdaq Compliance Notice

Funding Announcement

CEO Equity Awards

Audit Committee Compliance

Board Appointment

Asset Acquisitions

Debt-Equity Swaps

Contract Termination

Shareholder Meeting

Kokomodo Acquisition

Securities Offering

Private Placement Offering

Nasdaq Compliance Notice

Nasdaq Compliance Notice

Nasdaq Compliance

Agreement with Agriculture ...

Management Changes

Annual Meeting of Stockholders

Agreement and License Agree...

Compliance Regained

Reverse Share Split

Sales Agreement

Launch of Cell-based Coffee...

New Business Division Launch

Annual Meeting Results

Annual Meeting Announcement

Compliance Regained

External Links:

On April 15, 2025, Pluri Inc.'s subsidiary, Pluri Biotech Ltd., had a $4.2 million contract with NIAID terminated for the government's convenience, effective immediately, which may indicate broader federal budget adjustments.

AI Assistant

PLURI INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.